| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Precision BioSciences, Inc.
13G/A
DTIL · 74019P207
|
0% |
8/6/2025
Event 6/30/2025
|
||||
| Aquilo Capital, L.P. | 0% | |||||
| Aquilo Capital Management, LLC | 0% | |||||
| Marc Schneidman | 0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.